You are here
SBIR Phase I: Structure-based drug discovery for intrinsically disordered proteins
Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 2026142
Agency Tracking Number: 2026142
Amount:
$255,872.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
PT
Solicitation Number:
N/A
Timeline
Solicitation Year:
2020
Award Year:
2020
Award Start Date (Proposal Award Date):
2020-09-01
Award End Date (Contract End Date):
2021-08-31
Small Business Information
130 BOWDOIN ST APT 1204
BOSTON, MA
02108
United States
DUNS:
117079833
HUBZone Owned:
No
Woman Owned:
Yes
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: Virginia Burger
Phone: (201) 981-6633
Email: virginia@newequilibriumbio.com
Phone: (201) 981-6633
Email: virginia@newequilibriumbio.com
Business Contact
Name: Virginia Burger
Phone: (201) 981-6633
Email: virginia@newequilibriumbio.com
Phone: (201) 981-6633
Email: virginia@newequilibriumbio.com
Research Institution
N/A
Abstract
The broader impact/commercialization potential of this Small Business Innovation Research (SBIR) Phase I project is to enable drug discovery for life-threatening diseases. A group of proteins involved in cancers and neurodegenerative disorders, as well as
* Information listed above is at the time of submission. *
